Beyhan Ataseven
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 54
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 29
- Cancer Research top 2%
- Breast Cancer Treatment Studies 29
- Cancer Genomics and Diagnostics 14
- Oncology top 5%
- HER2/EGFR in Cancer Research 19
-
- Breast Lesions and Carcinomas 13
-
- Intraperitoneal and Appendiceal Malignancies 15
-
- BRCA gene mutations in cancer 12
In The Last Decade
Beyhan Ataseven
110 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 105
- Reproductive Medicine 752
- Obstetrics and Gynecology 468
- Cancer Research 685
- Oncology 935
- Pathology and Forensic Medicine 345
Countries citing papers authored by Beyhan Ataseven
This map shows the geographic impact of Beyhan Ataseven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beyhan Ataseven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beyhan Ataseven more than expected).
Fields of papers citing papers by Beyhan Ataseven
This network shows the impact of papers produced by Beyhan Ataseven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beyhan Ataseven. The network helps show where Beyhan Ataseven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beyhan Ataseven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 9 | |
| 14 | 2018 | 27 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 17 | |
| 17 | 2016 | 1 | |
| 18 | PTK7 expression in triple-negative breast cancer. | 2013 | 32 |
| 19 | 2012 | 44 | |
| 20 | 2011 | 13 |
About Beyhan Ataseven
Beyhan Ataseven is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 124 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (54 papers), Endometrial and Cervical Cancer Treatments (29 papers), Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (19 papers), Intraperitoneal and Appendiceal Malignancies (15 papers), Cancer Genomics and Diagnostics (14 papers), Breast Lesions and Carcinomas (13 papers) and BRCA gene mutations in cancer (12 papers). The work is most often cited by research in Reproductive Medicine (752 citations), Obstetrics and Gynecology (468 citations) and Cancer Research (685 citations). Beyhan Ataseven has collaborated with scholars based in Germany, Austria and Italy. Frequent co-authors include Philipp Harter, Andreas du Bois, Florian Heitz, Alexander Traut, Sonia Prader, Gϋnter von Minckwitz, Christoph Grimm, Sibylle Loibl, Sebastian Heikaus and Carsten Denkert.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.